SOURCE: NuVasive, Inc.

NuVasive, Inc.

May 13, 2016 07:00 ET

NuVasive to Feature Game-Changing, Integrated Spine Solutions at SpineWeek 2016

SAN DIEGO, CA--(Marketwired - May 13, 2016) - NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced it will exhibit more than 20 surgical solutions at SpineWeek 2016, being held May 16 - 20 in Singapore.

NuVasive will feature its market-leading, procedurally-integrated platform, the Integrated Global Alignment (iGA™) system, which is designed to help surgeons achieve more precise spinal column alignment. The multi-product suite of spine technologies form a complete procedural platform and operating philosophy that centers on the critical importance of proper spinal alignment for successful patient outcomes.

The Company will also showcase its innovative XLIF® procedure, the only lateral approach procedure validated by more than 10 years of clinical experience. In addition to iGA and XLIF, NuVasive will feature its full line of procedural offerings, including MAS PLIF/MAS TLIF, Cervicothoracic options and its multiple Posterior Fixation systems for open and minimally invasive surgery. Notably, NuVasive will demonstrate the recently added MAGnetic External Control, or MAGEC®, early-onset scoliosis spinal bracing and distraction system. Demonstrations are available at NuVasive Booth #F01.

Jason Hannon, NuVasive Executive Vice President, International, commented, "As we continue to expand our highly differentiated, minimally invasive spinal solutions worldwide, we are excited to participate in the first-ever Asian SpineWeek meeting. In 2016 and beyond, we are introducing new technologies into our expanding markets to enable improved patient outcomes and better economics for our customers."

"These are exciting times for NuVasive, as we are in the early stages of introducing our advanced procedural solutions to surgeons globally. Our customers are beginning to see how in partnership with NuVasive, they can increase their surgical options, help reduce morbidity and improve patient outcomes," Hannon continued. "We look forward to demonstrating how our industry-leading technologies like iGA, XLIF and MAS PLIF/TLIF, combined with unmatched clinical education offerings taught by renowned faculty, can help deliver superior and reproducible outcomes for patients," Hannon continued.

NuVasive SpineWeek Participation Details

The Company continues to focus on surgeon education and professional development, supporting numerous workshops, technology demonstrations and symposiums. NuVasive will host the following events:

Lunch Workshops:

Tuesday, May 17:

     
  Title: Importance of Pre-op Planning and Intra-op Assessment for Degenerative Disorders
  Faculty: Dr. Pedro Berjano, M.D., Ph.D., Prof. Claudio Lamartina, M.D. and Prof. Dr. Markus Quante
  Time: 12:00 - 14:00 SGT
  Location: Jasmine 12
     

Wednesday, May 18:

     
  Title: Anterior Column Realignment (ACR®): Anterior Techniques to Restore Spinal Alignment
  Faculty: Dr. Pedro Berjano, M.D., Ph.D., Prof. Claudio Lamartina, M.D. and Prof. Dr. Markus Quante
  Time: 12:00 - 14:00 SGT
  Location: Jasmine 12
     

Presentations at NuVasive Booth #F01:

Tuesday, May 17:

     
  Title: XLIF: XLIF Expanded Applications
  Faculty: Dr. Ashish Diwan, M.D. and Dr. William Smith, M.D.
  Time: 10:00 SGT
     
  Title: iGA: Methods of Pre-op Planning and Intra-op Assessment
  Faculty: Prof. Dr. Markus Quante
  Time: 16:00 SGT
     

Wednesday, May 18:

     
  Title: XLIF/XLIF TDR: XLIF Expanded Applications
  Faculty: Dr. Neil Cleaver, M.D., Dr. Luiz Pimenta, M.D., Ph.D. and Dr. William Smith, M.D.
  Time: 10:00 SGT
     
  Title: iGA: Methods of Pre-op Planning and Intra-op Assessment
  Faculty: Prof. Dr. Markus Quante and Dr. Pedro Berjano, M.D., Ph.D.
  Time: 16:00 SGT
     

Thursday, May 19:

     
  Title: MAGEC: A Revolutionary Treatment for Early Onset Scoliosis
  Faculty: Dr. Behrooz Akbarnia, M.D.
  Time: 10:00 SGT
     

European Spine Journal (ESJ) Symposium:

Tuesday, May 17:

     
  Title: Spine Science Forum: Meet the Experts, Osteotomies and Alternative Techniques in the Correction of Adult Deformity
  Faculty Chairs: Dr. Pedro Berjano, M.D., Ph.D. and Prof. Claudio Lamartina, M.D.
  Time: 8:00 - 12:45 SGT
  Location: Hibiscus
     

Asia Pacific Spine Society (APSS) Satellite Symposiums:

Friday, May 20:

     
  Title: Recent Advancements in Treatment of EOS Spine: Anterior vs. Posterior
  Faculty Chair: Prof. Gabriel Liu
  Time: 12:45 - 13:45 SGT
  Location: Room 1
     

About  NuVasive

NuVasive is a global medical device company focused on transforming spine surgery by empowering surgeons with technology to approach procedures in the least disruptive way possible and restore the vitality of life for those that suffer from debilitating spinal conditions. Through its minimally invasive, procedurally-integrated solutions, the Company is expanding the boundaries of modern healthcare with technologies and surgeon training designed to provide reproducible and clinically-proven surgical outcomes that are redefining the success factors of spine surgery like never before. Addressing a variety of pathologies up and down the spine, from complex spinal deformity to degenerative spinal conditions, NuVasive's highly differentiated solutions include access instruments, implantable hardware and increasingly expert software systems like its game-changing iGA™ surgical planning and reconciliation technology that centers on achieving the global alignment of the spine. NuVasive believes its integrated approach and expertise can fundamentally evolve spine care by delivering improved patient experiences, and better economics healthcare systems. With $811 million in revenues as of the end of 2015, NuVasive has an approximate 1,600 person workforce in more than 40 countries around the world. For more information on the Company, please visit www.nuvasive.com.

NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products (including the iGA™ platform), the Company's ability to effectually manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

Contact Information